Centrient Pharmaceuticals announces its achievement of a significant milestone in the clean production of antibiotics

May 19, 2022

Being the first company to publicly announce 100% PNEC compliance for its entire oral antibiotics product range Rijswijk, The Netherlands, May 19, 2022 (GLOBE NEWSWIRE) — Summary Centrient Pharmaceuticals reached a significant milestone in the clean production of its antibiotics, with the lowest environmental impact and minimizing the potential contribution to antimicrobial resistance The company […]

Advance Local is New Sophi.io Customer

May 19, 2022

TORONTO, May 18, 2022 (GLOBE NEWSWIRE) — Advance Local, one of the largest media groups in the United States operating 10 leading news and information organizations and reaching 55 million people monthly, has quadrupled their subscription goal using Sophi Content Paywall Engine. Faced with advertising pressures exacerbated by the Coronavirus, Advance Local increased subscription conversions […]

Landmark Meeting Urges Prioritization of Water and Sanitation to get Health, Climate and Economic Targets Back on Track

May 18, 2022

JAKARTA, Indonesia, May 18, 2022 /PRNewswire/ — More than 350 participants from 57 countries gathered today in Jakarta for the opening of the Sector Ministers’ Meeting which will generate urgent prioritization of water and sanitation worldwide. Among them were 50 ministers of water, sanitation, health, environment and the economy, who met to discuss the COVID-19 […]

WHR Group, Inc. Named a Top Workplace for the Ninth Consecutive Year

May 17, 2022

MILWAUKEE, Wis., May 17, 2022 (GLOBE NEWSWIRE) — For the ninth consecutive year, WHR Group, Inc. (WHR) was named a Top Workplace by the Milwaukee Journal Sentinel. Top Workplaces surveys employee engagement and satisfaction at companies throughout the US. Awards are given to companies in different regions including the Northeast, Southeast, Midwest, Southwest, Rocky Mountains and […]

Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

May 16, 2022

WALTHAM, Mass. and SHANGHAI, China, May 15, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, today announced the submission of an investigational new drug (IND) application to the China National Medical Products Administration […]

Zenas BioPharma Submits Investigational New Drug Application in China for ZB001 for the Treatment of Thyroid Eye Disease

May 16, 2022

WALTHAM, Mass. and SHANGHAI, China, May 15, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immune-based therapies for patients in need around the world, today announced the submission of an investigational new drug (IND) application to the China National Medical Products Administration […]